Europe’s immuno-oncology pipeline has a translation problem. Can SITC’s Lausanne summit fix it?
SITC’s Lausanne summit will connect regulators, biotech and academia to sharpen Europe’s path from immuno-oncology science to clinical trials.
Pharma & Biotech